The week in prescription drug pricing: what moved, what it means for patients, and what comes next.
New polling from Axios-Ipsos shows that health care costs — particularly prescription drug prices — will be a defining issue in the 2026 midterms, with a majority of voters saying a candidate’s…
News Jun 18, 2026Yesterday, the Senate HELP Committee advanced two bipartisan and P4ADNow-supported bills: The Biosimilar Red Tape Elimination Act (S. 1954), which would reduce unnecessary regulatory hurdles that…
News Jun 12, 2026The Senate HELP Committee is set to markup several bipartisan bills on Wednesday aimed at increasing competition and lowering drug prices.
News Jun 5, 2026Patients For Affordable Drugs Now released a new video featuring patient advocates and staff highlighting the bipartisan ETHIC Act ahead of this week’s House Judiciary hearing on patent law and prescription drug access.
News May 29, 2026This week, Patients For Affordable Drugs Now, AARP, and the ERISA Industry Committee (ERIC) sent a joint letter to congressional leadership urging Congress to pass the ETHIC Act.
News May 22, 2026The Supreme Court denied petitions from six major drugmakers — AstraZeneca, Bristol Myers Squibb, Janssen, Novartis, Novo Nordisk, and Boehringer Ingelheim— leaving in place lower court rulings that…
News May 15, 2026Generic versions of semaglutide – the active ingredient in Ozempic and Wegovy – are beginning to enter the market in countries such as India and Canada.
News May 8, 2026More than 40,000 vetted patient stories are now featured on P4AD’s interactive map, representing every state and congressional district and documenting the harm of high drug prices.
News May 1, 2026The Supreme Court heard arguments this week in a case that could limit how and when lower-cost generics come to market.
News Apr 24, 2026Over the last two weeks, P4AD patient advocates from across the country traveled to Washington, D.C., to share what high drug prices mean in real terms — skipped doses, delayed care, and impossible financial tradeoffs.